Viewing Study NCT05427669

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:52 PM
Ignite Modification Date: 2026-02-20 @ 4:46 PM
Study NCT ID: NCT05427669
Status: NOT_YET_RECRUITING
Last Update Posted: 2022-10-07
First Post: 2022-06-17
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Adjuvant mFOLFOXIRI vs. mFOLFOX6 in MRD Positive Stage II-III Colorectal Cancer (AFFORD)
Sponsor: Yanhong Deng
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Adjuvant chemotherapy View
None mFOLFOXIRI View
None mFOLFOX6 View
None minimal residual disease (MRD) View